|
"lin ch"的相關文件
顯示項目 136-145 / 823 (共83頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2020 |
Long-Term Outcomes and Risk Factors of Renal Failure Requiring Dialysis after Heart Transplantation: A Nationwide Cohort Study
|
Wang, TJ; Lin, CH; Wei, HJ; Wu, MJ |
| 中山醫學大學 |
2020 |
The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis
|
Cheng, YY; Chang, ST; Kao, CL; Chen, YH; Lin, CH |
| 中山醫學大學 |
2020 |
Association between EGFR Gene Mutation and Antioxidant Gene Polymorphism of Non-Small-Cell Lung Cancer
|
Lin, CH; Yang, PJ; Lin, SH; Yeh, KT; Tsao, TCY; Chen, YE; Lin, SH; Yang, SF |
| 中山醫學大學 |
2020 |
IMPLEMENTATION OF AN ELECTRONIC DASHBOARD WITH A REMOTE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC MANAGEMENT AMONG HOSPITALIZED ADULTS
|
Sheen, YJ; Huang, CC; Huang, SC; Huang, MD; Lin, CH; Lee, IT; Lin, SY; Sheu, WHH |
| 中山醫學大學 |
2020 |
Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study
|
Chen, HH; Lin, CH; Lai, KL; Hsieh, TY; Chen, YM; Tseng, CW; Gotcher, DF; Chang, YM; Chiou, CC; Liu, SC; Weng, SJ |
| 中山醫學大學 |
2020 |
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
|
Yu, YY; Tsao, SM; Yang, WT; Huang, WC; Lin, CH; Chen, WW; Yang, SF; Chiou, HL; Huang, YW |
| 中山醫學大學 |
2020 |
Factors associated with sepsis risk in immune-mediated inflammatory diseases receiving tumor necrosis factor inhibitors: a nationwide study
|
Chao, WC; Wang, CY; Hsu, BC; Lin, CH; Huang, WN; Chen, YH; Wu, CL; Chen, HH |
| 中山醫學大學 |
2020 |
Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case-control study in Taiwan
|
Chen, HH; Yong, YM; Lin, CH; Chen, YH; Chen, DY; Ying, JC; Chao, WC |
| 中山醫學大學 |
2020 |
Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
|
Chen, JF; Chen, HS; Chu, CH; Chuang, LM; Ho, LT; Hung, YJ; Kuo, CH; Li, HY; Lin, CH; Lin, KD; Lin, SY; Sheen, YJ; Sheu, WHH; Shin, SJ; Tsai, ST; Te Tu, S; Bai, CH; Chang, YC; Chang, TJ; Chang, CH; Chang, CJ; Chao, CC; Chen, CC; Chen, YL; Chong, K; Chuang, WL; Guo, LY; Hsieh, MC; Hsu, CC; Huang, LC; Huang, CN; Huang, YY; Hung, CS; Hung, WW; Hwu, CM; Jeng, JS; Jiang, YD; Juang, JMJ; Juang, JH; Kuo, CS; Kuo, JF; Kwok, CF; Lai, YC; Lee, MY; Lee, YJ; Lee, IT; Lee, CN; Lee, YT; Lee, TI; Lee, CH; Lin, LY; Lin, SD; Lin, KY; Lin, HJ; Lin, CH; Liu, CE; Lo, FS; Lu, CH; Lu, KC; Ma, WY; Ou, HY; Pei, D; Su, CC; Su, SL; Tan, ECH; Tien, KJ; Tsai, LK; Tseng, CH; Wang, JS; Weng, SF; Wu, WC; Yang, MC; Yang, YS; Yang, CH; Yang, WS; Yeh, JT; Yu, NC; Yu, TY |
| 中山醫學大學 |
2020 |
Buffer areas in emergency department to handle potential COVID-19 community infection in Taiwan
|
Chen, TY; Lai, HW; Hou, IL; Lin, CH; Chen, MK; Chou, CC; Lin, YR |
顯示項目 136-145 / 823 (共83頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
|
